ORTX
Orchard Therapeutics plc American Depositary Shares
ORTX
ORTX
Delisted
ORTX was delisted on the 23rd of January, 2024.
72 hedge funds and large institutions have $84.6M invested in Orchard Therapeutics plc American Depositary Shares in 2021 Q4 according to their latest regulatory filings, with 18 funds opening new positions, 14 increasing their positions, 26 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
53% less call options, than puts
Call options by funds: $82K | Put options by funds: $175K
Holders
72
Holding in Top 10
–
Calls
$82K
Puts
$175K
Top Buyers
| 1 | +$3.13M | |
| 2 | +$3.13M | |
| 3 | +$858K | |
| 4 |
Two Sigma Investments
New York
|
+$716K |
| 5 |
AFM
Anson Funds Management
Dallas,
Texas
|
+$460K |
Top Sellers
| 1 | -$8.82M | |
| 2 | -$5.92M | |
| 3 | -$3.06M | |
| 4 |
VC
Vivo Capital
Palo Alto,
California
|
-$3.05M |
| 5 |
JPMorgan Chase & Co
New York
|
-$1.81M |